Paper35224973
PET Imaging of Small Extracellular Vesicles via [89Zr]Zr(oxinate)4 Direct Radiolabeling.
Khan AA and 11 others. Bioconjug Chem, 2022. Cited by 45 papers, by iCite.
Cite this record
ConductScience Library. PET Imaging of Small Extracellular Vesicles via [89Zr]Zr(oxinate)4 Direct Radiolabeling. Papers, record 35224973. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/35224973
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Extracellular Vesicles | Major topic |
| Pancreatic Neoplasms | Major topic |
| Animals | |
| Cell Line, Tumor | |
| Mice | |
| Positron-Emission Tomography | |
| Tissue Distribution | |
| Zirconium |
Source PubMed
Grants3
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| WT 084052/Z/07/Z | Wellcome Trust | United Kingdom | PubMed | |
| MR/N013700/1 | Medical Research Council | United Kingdom | PubMed | |
| WT/203148/Z/16/Z | Wellcome Trust | United Kingdom | PubMed |
Source PubMed
References49
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 27979573 | Extracellular Vesicles: Unique Intercellular Delivery Vehicles. | Trends Cell Biol | 2017 | https://conductscience.org/library/papers/27979573 | PubMed |
| 2 | 28667694 | Accelerated growth of B16BL6 tumor in mice through efficient uptake of their own exosomes by B16BL6 cells. | Cancer Sci | 2017 | https://conductscience.org/library/papers/28667694 | PubMed |
| 3 | 27781436 | Exploiting the Metal-Chelating Properties of the Drug Cargo for In Vivo Positron Emission Tomography Imaging of Liposomal Nanomedicines. | ACS Nano | 2016 | https://conductscience.org/library/papers/27781436 | PubMed |
| 4 | 21423189 | Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes. | Nat Biotechnol | 2011 | https://conductscience.org/library/papers/21423189 | PubMed |
| 5 | 18228490 | Isolation and characterization of exosomes from cell culture supernatants and biological fluids. | Curr Protoc Cell Biol | 2006 | https://conductscience.org/library/papers/18228490 | PubMed |
| 6 | 29386907 | Exosome-mediated delivery of MALAT1 induces cell proliferation in breast cancer. | Onco Targets Ther | 2018 | https://conductscience.org/library/papers/29386907 | PubMed |
| 7 | 18589210 | MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer. | Gynecol Oncol | 2008 | https://conductscience.org/library/papers/18589210 | PubMed |
| 8 | 29535851 | Glycosylation of extracellular vesicles: current knowledge, tools and clinical perspectives. | J Extracell Vesicles | 2018 | https://conductscience.org/library/papers/29535851 | PubMed |
| 9 | 33407513 | Hydrophobic insertion-based engineering of tumor cell-derived exosomes for SPECT/NIRF imaging of colon cancer. | J Nanobiotechnology | 2021 | https://conductscience.org/library/papers/33407513 | PubMed |
| 10 | 15389672 | Antibody pharmacokinetics and pharmacodynamics. | J Pharm Sci | 2004 | https://conductscience.org/library/papers/15389672 | PubMed |
| 11 | 33470092 | Selection of Fluorescent, Bioluminescent, and Radioactive Tracers to Accurately Reflect Extracellular Vesicle Biodistribution in Vivo. | ACS Nano | 2021 | https://conductscience.org/library/papers/33470092 | PubMed |
| 12 | 28604595 | Emerging Role of the Spleen in the Pharmacokinetics of Monoclonal Antibodies, Nanoparticles and Exosomes. | Int J Mol Sci | 2017 | https://conductscience.org/library/papers/28604595 | PubMed |
| 13 | 12154376 | Exosomes: composition, biogenesis and function. | Nat Rev Immunol | 2002 | https://conductscience.org/library/papers/12154376 | PubMed |
| 14 | 30872574 | Extracellular vesicle-based therapeutics: natural versus engineered targeting and trafficking. | Exp Mol Med | 2019 | https://conductscience.org/library/papers/30872574 | PubMed |
| 15 | 28184302 | The role of exosomes in the pathogenesis of Alzheimer' disease. | Transl Neurodegener | 2017 | https://conductscience.org/library/papers/28184302 | PubMed |
| 16 | 24255917 | CD169 mediates the capture of exosomes in spleen and lymph node. | Blood | 2014 | https://conductscience.org/library/papers/24255917 | PubMed |
| 17 | 27310303 | Radiolabeling of Extracellular Vesicles with (99m)Tc for Quantitative In Vivo Imaging Studies. | Cancer Biother Radiopharm | 2016 | https://conductscience.org/library/papers/27310303 | PubMed |
| 18 | 26923139 | Cellular uptake of PLA nanoparticles studied by light and electron microscopy: synthesis, characterization and biocompatibility studies using an iridium(III) complex as correlative label. | Chem Commun (Camb) | 2016 | https://conductscience.org/library/papers/26923139 | PubMed |
| 19 | 25393546 | Quantitative analysis of tissue distribution of the B16BL6-derived exosomes using a streptavidin-lactadherin fusion protein and iodine-125-labeled biotin derivative after intravenous injection in mice. | J Pharm Sci | 2015 | https://conductscience.org/library/papers/25393546 | PubMed |
| 20 | 30429045 | In Vivo PET Tracking of 89Zr-Labeled Vγ9Vδ2 T Cells to Mouse Xenograft Breast Tumors Activated with Liposomal Alendronate. | Mol Ther | 2019 | https://conductscience.org/library/papers/30429045 | PubMed |
Cited by34
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 45 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42820365 | Role of Extracellular Vesicles in Shaping Immune Responses in the Lymph Node Microenvironment. | Biol Cell | 2026 | https://conductscience.org/library/papers/42820365 | PubMed |
| 42699777 | A product control framework for extracellular vesicle therapeutics: Quality attributes, stability, analytical procedures, and biodistribution. | Int J Pharm X | 2026 | https://conductscience.org/library/papers/42699777 | PubMed |
| 42534150 | Radiolabeled exosomes for theranostics: Personalized tailored therapy through imaging. | World J Radiol | 2026 | https://conductscience.org/library/papers/42534150 | PubMed |
| 42352457 | Engineered Exosomes in Precision Neuro-Oncology: Mechanisms, Therapeutics, and Translational Challenges. | Cancers (Basel) | 2026 | https://conductscience.org/library/papers/42352457 | PubMed |
| 42198464 | NIS-Centered Reporter Gene Imaging and Radionuclide-Integrated Nanoplatforms for Quantitative Tracking of Immune Cell Therapy in Oncology and Inflammatory Disease Models. | Pharmaceuticals (Basel) | 2026 | https://conductscience.org/library/papers/42198464 | PubMed |
| 42139331 | Helper lipid-engineered extracellular vesicles enable PET imaging-guided pulmonary siRNA delivery to treat lung metastasis. | Sci Adv | 2026 | https://conductscience.org/library/papers/42139331 | PubMed |
| 42126515 | Engineered Exosomes: Innovative Strategies for Precision Drug Delivery in Parkinson's Disease. | Mol Neurobiol | 2026 | https://conductscience.org/library/papers/42126515 | PubMed |
| 42122007 | Extracellular Vesicles in Myocardial Infarction: Dual Role in Ferroptosis Regulation and In Vivo Imaging. | Diagnostics (Basel) | 2026 | https://conductscience.org/library/papers/42122007 | PubMed |
| 42058105 | Extracellular Vesicles in Osteoarthritis: From Pathogenic Mediators to Engineered Therapeutics in a Precision Medicine Roadmap. | J Extracell Biol | 2026 | https://conductscience.org/library/papers/42058105 | PubMed |
| 41968322 | Surface engineering of extracellular vesicles: trends, strategies, and applications in diagnosis and therapy. | J Nanobiotechnology | 2026 | https://conductscience.org/library/papers/41968322 | PubMed |
| 41776618 | Visualizing extracellular vesicles in cancer: from biogenesis to theranostic applications. | J Nanobiotechnology | 2026 | https://conductscience.org/library/papers/41776618 | PubMed |
| 41686219 | Tracking macrophages by direct and indirect 89Zr PET imaging. | Eur J Nucl Med Mol Imaging | 2026 | https://conductscience.org/library/papers/41686219 | PubMed |
| 41378821 | Optimizing Exosome Lipid Hybrid Nanoparticles for Enhanced siRNA Delivery and Improved Therapeutic Anticancer Efficacy In Vivo. | ACS Nano | 2025 | https://conductscience.org/library/papers/41378821 | PubMed |
| 40532508 | Biodistribution studies of 89Zr-Labeled stem cell-derived exosomes using PET imaging. | Appl Radiat Isot | 2025 | https://conductscience.org/library/papers/40532508 | PubMed |
| 39741408 | In vivo tracking of ex-vivo-generated 89Zr-oxine-labeled plasma cells by PET in a non-human primate model. | Mol Ther | 2025 | https://conductscience.org/library/papers/39741408 | PubMed |
| 38904206 | BMSC‑derived exosome‑mediated miR‑25‑3p delivery protects against myocardial ischemia/reperfusion injury by constraining M1‑like macrophage polarization. | Mol Med Rep | 2024 | https://conductscience.org/library/papers/38904206 | PubMed |
| 38766658 | Neural Stem Cell-Derived Small Extracellular Vesicles: key Players in Ischemic Stroke Therapy - A Comprehensive Literature Review. | Int J Nanomedicine | 2024 | https://conductscience.org/library/papers/38766658 | PubMed |
| 38675383 | Long-Term Tumor-Targeting Effect of E. coli as a Drug Delivery System. | Pharmaceuticals (Basel) | 2024 | https://conductscience.org/library/papers/38675383 | PubMed |
| 38612553 | Standard Radio-Iodine Labeling Protocols Impaired the Functional Integrity of Mesenchymal Stem/Stromal Cell Exosomes. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/38612553 | PubMed |
| 38241003 | Physio-chemical Modifications to Re-engineer Small Extracellular Vesicles for Targeted Anticancer Therapeutics Delivery and Imaging. | ACS Biomater Sci Eng | 2024 | https://conductscience.org/library/papers/38241003 | PubMed |
Genes6
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CANX | 821 | PubTator's text mining | https://conductscience.org/library/genes/821 | NCBI Gene |
| CD63 | 967 | PubTator's text mining | https://conductscience.org/library/genes/967 | NCBI Gene |
| CD81 | 975 | PubTator's text mining | https://conductscience.org/library/genes/975 | NCBI Gene |
| CD9 | 928 | PubTator's text mining | https://conductscience.org/library/genes/928 | NCBI Gene |
| FMOD | 2331 | PubTator's text mining | https://conductscience.org/library/genes/2331 | NCBI Gene |
| PDCD6IP | 10015 | PubTator's text mining | https://conductscience.org/library/genes/10015 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/35224973
GET https://conductscience.org/api/papers/v1/35224973/references?page=2